SCHEMBL6187035

SCHEMBL6187035

Cc1cccc(C)c1C(=O)c1c(C)[nH]c2ccc(NC(=O)C3CCC(=O)C3)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.48
PARP15 Q460N3 1/20 0.48
PARP10 Q53GL7 1/20 0.48
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
ULK1 O75385 3/20 0.39
STK17B O94768 2/20 0.38
STK17A Q9UEE5 2/20 0.38
DAPK3 O43293 1/20 0.38
DAPK1 P53355 1/20 0.38
DAPK2 Q9UIK4 1/20 0.38
BRD4 O60885 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6190881 0.91 PARP1 (0.47) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6189495 0.89 PARP1 (0.45) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6188460 0.89 MAOA (0.46) MAOAMAOBMAPTTP53ULK1
SCHEMBL6185141 0.87 PARP1 (0.44) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6187132 0.87 MAOA (0.50) MAOAMAOBMAPTTP53ULK1
SCHEMBL6189454 0.87 MAOA (0.53) MAOAMAOBMAPTTP53ULK1
SCHEMBL6188606 0.86 MAOA (0.55) MAOAMAOBMAPTTP53STK17B
SCHEMBL6187011 0.85 PARP1 (0.42) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6189327 0.79 HPGD (0.46) MAOAMAOBMAPTTP53ULK1
SCHEMBL6184788 0.79 MAOA (0.45) MAOAMAOBMAPTULK1STK17B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed